Literature DB >> 20524691

Conformation of dimeric apolipoprotein A-I milano on recombinant lipoprotein particles.

Shaila Bhat1, Mary G Sorci-Thomas, Laura Calabresi, Michael P Samuel, Michael J Thomas.   

Abstract

Apolipoprotein A-I Milano (apoA-I(Milano)) is a naturally occurring human mutation of wild-type apolipoprotein A-I (apoA-I(WT)) having cystine substituted for arginine(173). Two molecules of apo-I(WT) form disks with phospholipid having a defined relationship between the apoA-I(WT) molecules. ApoA-I(Milano) forms cystine homodimers that would not allow the protein to adopt the conformation reported for apoA-I(WT). The conformational constraints for dimeric apoA-I(Milano) recombinant high-density lipoprotein (rHDL) disks made with phospholipid were deduced from a combination of chemical cross-linking and mass spectrometry. Lysine-selective homobifunctional cross-linkers were reacted with homogeneous rHDL having diameters of 78 and 125 A. After reduction, cross-linked apoA-I(Milano) was separated from monomeric apoprotein by gel electrophoresis and then subjected to in-gel trypsin digest. Cross-linked peptides were confirmed by MS/MS sequencing. The cross-links provided distance constraints that were used to refine models of lipid-bound dimeric apoA-I(Milano). These studies suggest that a single dimeric apoA-I(Milano) on 78 A diameter rHDL girdles the edge of a phospholipid disk assuming a "belt" conformation similar to the "belt" region of apoA-I(WT) on rHDL. However, the C-terminal end of dimeric apoA-I(Milano) wraps around the periphery of the particle to shield the fatty acid chains from water rather than folding back onto the "belt" as does apoA-I(WT). The two apoA-I(Milano) dimers on a 125 A diameter rHDL do not encircle the periphery of a phospholipid disk but appear to reside on the surface of a laminar micelle.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20524691      PMCID: PMC2946800          DOI: 10.1021/bi1003734

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  72 in total

1.  Cardiovascular status of carriers of the apolipoprotein A-I(Milano) mutant: the Limone sul Garda study.

Authors:  C R Sirtori; L Calabresi; G Franceschini; D Baldassarre; M Amato; J Johansson; M Salvetti; C Monteduro; R Zulli; M L Muiesan; E Agabiti-Rosei
Journal:  Circulation       Date:  2001-04-17       Impact factor: 29.690

2.  Three arginine residues in apolipoprotein A-I are critical for activation of lecithin:cholesterol acyltransferase.

Authors:  S Roosbeek; B Vanloo; N Duverger; H Caster; J Breyne; I De Beun; H Patel; J Vandekerckhove; C Shoulders; M Rosseneu; F Peelman
Journal:  J Lipid Res       Date:  2001-01       Impact factor: 5.922

Review 3.  Managing the risk of atherosclerosis: the role of high-density lipoprotein.

Authors:  P Libby
Journal:  Am J Cardiol       Date:  2001-12-20       Impact factor: 2.778

4.  Structural determination of lipid-bound ApoA-I using fluorescence resonance energy transfer.

Authors:  H Li; D S Lyles; M J Thomas; W Pan; M G Sorci-Thomas
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

Review 5.  The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function.

Authors:  J P Segrest; M K Jones; H De Loof; C G Brouillette; Y V Venkatachalapathi; G M Anantharamaiah
Journal:  J Lipid Res       Date:  1992-02       Impact factor: 5.922

6.  Intermolecular contact between globular N-terminal fold and C-terminal domain of ApoA-I stabilizes its lipid-bound conformation: studies employing chemical cross-linking and mass spectrometry.

Authors:  Shaila Bhat; Mary G Sorci-Thomas; Eric T Alexander; Michael P Samuel; Michael J Thomas
Journal:  J Biol Chem       Date:  2005-06-22       Impact factor: 5.157

7.  Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation.

Authors:  D W Borhani; D P Rogers; J A Engler; C G Brouillette
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

8.  Activation of lecithin cholesterol acyltransferase by a disulfide-linked apolipoprotein A-I dimer.

Authors:  L Calabresi; G Franceschini; A Burkybile; A Jonas
Journal:  Biochem Biophys Res Commun       Date:  1997-03-17       Impact factor: 3.575

9.  Intramural delivery of recombinant apolipoprotein A-IMilano/phospholipid complex (ETC-216) inhibits in-stent stenosis in porcine coronary arteries.

Authors:  Sanjay Kaul; Vladimir Rukshin; Raul Santos; Babak Azarbal; Charles L Bisgaier; Jan Johansson; Vivian T Tsang; Kuang-Yuh Chyu; Bojan Cercek; James Mirocha; Prediman K Shah
Journal:  Circulation       Date:  2003-05-12       Impact factor: 29.690

10.  Heteronuclear NMR studies of human serum apolipoprotein A-I. Part I. Secondary structure in lipid-mimetic solution.

Authors:  Mark Okon; Philippe G Frank; Yves L Marcel; Robert J Cushley
Journal:  FEBS Lett       Date:  2002-04-24       Impact factor: 4.124

View more
  10 in total

1.  Dysfunctional HDL containing L159R ApoA-I leads to exacerbation of atherosclerosis in hyperlipidemic mice.

Authors:  Mary G Sorci-Thomas; Manal Zabalawi; Manish S Bharadwaj; Ashley J Wilhelm; John S Owen; Bela F Asztalos; Shaila Bhat; Michael J Thomas
Journal:  Biochim Biophys Acta       Date:  2011-09-14

2.  Rotational and hinge dynamics of discoidal high density lipoproteins probed by interchain disulfide bond formation.

Authors:  Ling Li; Songlin Li; Martin K Jones; Jere P Segrest
Journal:  Biochim Biophys Acta       Date:  2011-10-19

3.  Self-association of an insect β-1,3-glucan recognition protein upon binding laminarin stimulates prophenoloxidase activation as an innate immune response.

Authors:  Daisuke Takahashi; Huaien Dai; Yasuaki Hiromasa; Ramaswamy Krishnamoorthi; Michael R Kanost
Journal:  J Biol Chem       Date:  2014-08-21       Impact factor: 5.157

4.  S1P in HDL promotes interaction between SR-BI and S1PR1 and activates S1PR1-mediated biological functions: calcium flux and S1PR1 internalization.

Authors:  Mi-Hye Lee; Kathryn M Appleton; Hesham M El-Shewy; Mary G Sorci-Thomas; Michael J Thomas; Maria F Lopes-Virella; Louis M Luttrell; Samar M Hammad; Richard L Klein
Journal:  J Lipid Res       Date:  2016-11-23       Impact factor: 5.922

5.  Procollagen C-endopeptidase Enhancer Protein 2 (PCPE2) Reduces Atherosclerosis in Mice by Enhancing Scavenger Receptor Class B1 (SR-BI)-mediated High-density Lipoprotein (HDL)-Cholesteryl Ester Uptake.

Authors:  Ricquita D Pollard; Christopher N Blesso; Manal Zabalawi; Brian Fulp; Mark Gerelus; Xuewei Zhu; Erica W Lyons; Nebil Nuradin; Omar L Francone; Xiang-An Li; Daisy Sahoo; Michael J Thomas; Mary G Sorci-Thomas
Journal:  J Biol Chem       Date:  2015-05-06       Impact factor: 5.157

6.  Nascent high density lipoproteins formed by ABCA1 resemble lipid rafts and are structurally organized by three apoA-I monomers.

Authors:  Mary G Sorci-Thomas; John S Owen; Brian Fulp; Shaila Bhat; Xuewei Zhu; John S Parks; Dharika Shah; W Gray Jerome; Mark Gerelus; Manal Zabalawi; Michael J Thomas
Journal:  J Lipid Res       Date:  2012-06-29       Impact factor: 5.922

7.  High-Density Lipoprotein Biogenesis: Defining the Domains Involved in Human Apolipoprotein A-I Lipidation.

Authors:  Ricquita D Pollard; Brian Fulp; Mary G Sorci-Thomas; Michael J Thomas
Journal:  Biochemistry       Date:  2016-08-23       Impact factor: 3.162

Review 8.  Structural basis for distinct functions of the naturally occurring Cys mutants of human apolipoprotein A-I.

Authors:  Olga Gursky; Martin K Jones; Xiaohu Mei; Jere P Segrest; David Atkinson
Journal:  J Lipid Res       Date:  2013-09-13       Impact factor: 5.922

9.  The conformation of lipid-free human apolipoprotein A-I in solution.

Authors:  Ricquita D Pollard; Brian Fulp; Michael P Samuel; Mary G Sorci-Thomas; Michael J Thomas
Journal:  Biochemistry       Date:  2013-12-17       Impact factor: 3.162

Review 10.  Structural Insights into High Density Lipoprotein: Old Models and New Facts.

Authors:  Valentin Gogonea
Journal:  Front Pharmacol       Date:  2016-01-12       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.